Professor Chris Behrenbruch2014 Distinguished Alumni of the Year – Faculty of Engineering Professor Chris Behrenbruch (BE(Elec&Comp)(Hons) 1998) is a serial entrepreneur and Monash alumnus. Over the past decade Chris has been responsible...
2014 Distinguished Alumni of the Year – Faculty of Engineering
Professor Chris Behrenbruch (BE(Elec&Comp)(Hons) 1998) is a serial entrepreneur and Monash alumnus.
Over the past decade Chris has been responsible for starting or financing more than 20 innovative companies in the life sciences, material science, nanotechnology and healthcare IT space, mostly from technologies transferred out of the university setting.
Chris is currently the CEO of ImaginAb, Inc. a clinical stage biotechnology company with operations in Los Angeles, Singapore and Tokyo.
ImaginAb was launched in 2007 based on antibody technology in-licensed from Cornell University, the University of California (Los Angeles) and the City of Hope Medical Center.
Prior to ImaginAb, he was a Vice-President at Siemens Molecular Imaging following the successful acquisition of Mirada Solutions (Co-founder and CEO) and CTI Molecular Imaging (Sr. VP), where he was responsible for advanced medical imaging product development for clinical and drug discovery applications.
Chris completed his undergraduate studies at Monash University, received his D.Phil (PhD) in biomedical engineering from the University of Oxford, and an MBA jointly from New York University and the London School of Economics.
He is a World Economic Forum Young Global Leader (YGL) and was the recipient of the 2012 Advance Global Australian of Year in the field of biotechnology in recognition of both his commercial and philanthropic activities.
Closer to home, Chris is a founding member of RMIT Business School’s Industry Advisory Board, a Vice-Chancellor’s Professorial Fellow at Monash University and very much honoured to be the newest member of Monash’s Engineering Foundation Board.
He is splits his time between Melbourne and Los Angeles and attributes a large measure of his success to his wonderful and extremely tolerant wife, Zhenya. Chris has a two year old son named Max, who is infinitely more interesting than any start-up company attempted thus far.